3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 24 0 0 0 0 0 0 0999 V2000
3.1380 0.6323 -0.6064 F 0 0 0 0 0 0 0 0 0 0 0 0
1.3147 1.5843 0.1150 F 0 0 0 0 0 0 0 0 0 0 0 0
2.5532 0.4257 1.4843 F 0 0 0 0 0 0 0 0 0 0 0 0
1.8580 -1.8516 -0.0706 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0345 -0.5658 -0.4751 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8778 0.7306 0.7119 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.8143 0.1545 -0.1073 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1952 -1.0536 0.6071 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7421 1.2125 -0.3987 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0173 -1.6130 -0.1888 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5719 0.6079 -1.1745 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3011 -0.7518 -0.1198 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0880 0.4880 0.2229 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2523 -0.1796 -1.0564 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8437 -0.7568 1.6044 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9457 -1.8402 0.7502 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3673 1.6374 0.5418 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.1732 2.0383 -0.9775 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.5472 -2.4280 0.3719 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3562 -2.0212 -1.1481 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.9530 0.2285 -2.1330 H 0 0 0 0 0 0 0 0 0 0 0 0
0.1784 1.3427 -1.4654 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.3149 1.5042 0.2129 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.6081 0.0363 0.8645 H 0 0 0 0 0 0 0 0 0 0 0 0
1 13 1 0 0 0 0
2 13 1 0 0 0 0
3 13 1 0 0 0 0
4 12 2 0 0 0 0
5 10 1 0 0 0 0
5 11 1 0 0 0 0
5 12 1 0 0 0 0
6 7 1 0 0 0 0
6 23 1 0 0 0 0
6 24 1 0 0 0 0
7 8 1 0 0 0 0
7 9 1 0 0 0 0
7 14 1 0 0 0 0
8 10 1 0 0 0 0
8 15 1 0 0 0 0
8 16 1 0 0 0 0
9 11 1 0 0 0 0
9 17 1 0 0 0 0
9 18 1 0 0 0 0
10 19 1 0 0 0 0
10 20 1 0 0 0 0
11 21 1 0 0 0 0
11 22 1 0 0 0 0
12 13 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
1-(4-aminopiperidin-1-yl)-2,2,2-trifluoroethanone
4.2 InChl
InChI=1S/C7H11F3N2O/c8-7(9,10)6(13)12-3-1-5(11)2-4-12/h5H,1-4,11H2
4.3 InChlKey
IMIRFQOBCRHHFT-UHFFFAOYSA-N
4.4 Canonical SMILES
C1CN(CCC1N)C(=O)C(F)(F)F
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病